Human stem cell derived neurones and astrocytes as an in vitro model of human prion infection and replication
人类干细胞衍生的神经元和星形胶质细胞作为人类朊病毒感染和复制的体外模型
基本信息
- 批准号:NC/N001419/1
- 负责人:
- 金额:$ 34.24万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2015
- 资助国家:英国
- 起止时间:2015 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Prion diseases have a profound impact on animal and human health. This is especially true in the UK where the effects of bovine spongiform encephalopathy (BSE) and variant Creutzfeldt-Jakob disease (vCJD) remain a live public health issue, and in North America where chronic wasting disease in deer is considered a potential threat to human health, but it is also true worldwide where one in a million people every year die from sporadic or familial forms of the disease. Prion diseases resemble more common causes of dementia, such as Alzheimer's disease, in that they are characterised by the deposition of abnormally folded protein in the brain, but unlike Alzheimer's disease, prion diseases are demonstratively transmissible from one person or one animal to another. This relative ease of transmission between individuals has meant that animal experimentation has been the main stay of prion disease research for decades, first using rodents and monkeys and then using increasingly sophisticated genetically modified mice to model animal and human prion diseases. Transgenic mouse models of human prion disease are among the most useful of any of the currently available transgenic mouse model of human neurodegenerative disease, however they carry both an economic and ethical cost.The ability to infect human cells grown in culture with human prions would be a major advance and would lead to an acceleration in our understanding of prion diseases at the molecular and cellular level and consequently our ability to develop treatments for them. Previous attempts to infect human cells with human prion agent have been largely unsuccessful and to date there is no widely used cell culture model of any human prion disease. We have hypothesised that previous failures result from differences between the kinds of human cells that grow and multiply well in culture and the natural targets of prion in human brains, specialised brain cells called astrocytes and neurones. The ability to make functional human cells of many types (including astrocytes and neurones) from human embryonic and induced pluripotent stem cells offers much to biology and medicine, including cellular transplantation therapies, but it may also offer something extremely useful to prion disease research.We have characterised a series of human stem cell lines for the sequence and expression of the normal prion protein and selected the ones that we predict would be susceptible to vCJD prion infection based on what we learned from patients and from experimental animal studies. We then made these stem cells into astrocytes and exposed them to small quantities of human brain tissues from patients who died from vCJD. Our results show that human prions can indeed replicate in human cells in culture, provided that care is taken to use cells that closely resemble the cells affected in the brains of patients.We seek to capitalise on this observation by finding out (i) whether the neurones (in addition to astrocytes) can be infected with the vCJD prions, (ii) whether the prions associated with other forms of Creutzfeldt-Jakob disease can infect stem cell derived astrocytes and neurones, (iii) whether the cell culture system reproduces known genetic barriers to infection, (iv) if prion infection harms neurones and glia and (v) whether it affects the mutually supportive relationship between astrocytes and neurones. Lastly, we will develop a definitive method for measuring prion replication in cells. The results of these experiments will provide a sound basis on which to advocate the use of stem cell derived neurones and astrocytes as a replacement for experimental animals in specific kinds of basic and applied human prion research.
朊病毒疾病对动物和人类健康具有深远的影响。在英国尤其如此,牛海绵状脑病(BSE)和变异型克雅氏病(vCJD)的影响仍然是一个活生生的公共卫生问题,在北美,鹿的慢性消耗性疾病被认为是对人类健康的潜在威胁,但在全球范围内也是如此,每年有一百万人死于散发或家族性疾病。朊病毒疾病类似于痴呆症的更常见原因,如阿尔茨海默病,因为它们的特征是异常折叠蛋白质在大脑中的沉积,但与阿尔茨海默病不同,朊病毒疾病明显可从一个人或一种动物传播到另一种动物。这种相对容易在个体之间传播的特性意味着,几十年来,动物实验一直是朊病毒疾病研究的主要手段,首先使用啮齿动物和猴子,然后使用越来越复杂的转基因小鼠来模拟动物和人类朊病毒疾病。人朊病毒疾病的转基因小鼠模型是目前可获得的人神经变性疾病的任何转基因小鼠模型中最有用的,感染培养在人朊病毒中的人类细胞的能力将是一个重大的进步,并将加速我们在分子和细胞水平上对朊病毒疾病的理解,从而使我们有能力为他们开发治疗方法。以前用人朊病毒剂感染人细胞的尝试在很大程度上是不成功的,迄今为止,还没有广泛使用的任何人朊病毒疾病的细胞培养模型。我们假设,以前的失败是由于在培养中生长和繁殖良好的人类细胞与人类大脑中朊病毒的天然靶细胞(称为星形胶质细胞和神经元的专门脑细胞)之间的差异。制造多种功能性人体细胞的能力(包括星形胶质细胞和神经元)和诱导的多能干细胞为生物学和医学提供了很多,包括细胞移植疗法,但它也可能为朊病毒疾病的研究提供一些极其有用的东西。我们已经对一系列人类干细胞系的正常朊病毒蛋白质的序列和表达进行了表征,并选择了我们认为合适的干细胞系。根据我们从病人和实验动物研究中了解到的情况,我们预测可能易受vCJD朊病毒感染。然后,我们将这些干细胞制成星形胶质细胞,并将它们暴露于少量死于vCJD的患者的人脑组织中。我们的研究结果表明,人类朊病毒确实可以在培养的人类细胞中复制,只要小心使用与患者大脑中受影响细胞非常相似的细胞。(除了星形胶质细胞)可以被vCJD朊病毒感染,(ii)与其他形式的克雅氏病相关的朊病毒是否可以感染干细胞衍生的星形胶质细胞和神经元,(iii)细胞培养系统是否复制已知的感染遗传屏障,(iv)朊病毒感染是否损害神经元和神经胶质细胞,以及(v)它是否影响星形胶质细胞和神经元之间的相互支持关系。最后,我们将开发一种确定的方法来测量朊病毒在细胞中的复制。这些实验的结果将提供一个坚实的基础,在此基础上,倡导使用干细胞衍生的神经元和星形胶质细胞作为替代实验动物在特定种类的基础和应用人类朊病毒的研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Siddharthan Chandran其他文献
The immediate impact of the COVID-19 pandemic on motor neuron disease services and mortality in Scotland
- DOI:
10.1007/s00415-020-10207-9 - 发表时间:
2020-09-05 - 期刊:
- 影响因子:4.600
- 作者:
Stella A. Glasmacher;Juan Larraz;Arpan R. Mehta;Patrick K. A. Kearns;Michael Wong;Judith Newton;Richard Davenport;George Gorrie;Ian Morrison;Javier Carod Artal;Siddharthan Chandran;Suvankar Pal - 通讯作者:
Suvankar Pal
Role of glia in delirium: proposed mechanisms and translational implications
胶质细胞在谵妄中的作用:提出的机制和转化意义
- DOI:
10.1038/s41380-024-02801-4 - 发表时间:
2024-10-27 - 期刊:
- 影响因子:10.100
- 作者:
Áine Bríd Heffernan;Moritz Steinruecke;Georgia Dempsey;Siddharthan Chandran;Bhuvaneish T. Selvaraj;Zoeb Jiwaji;Maria Stavrou - 通讯作者:
Maria Stavrou
Riluzole prescribing, uptake and treatment discontinuation in people with amyotrophic lateral sclerosis in Scotland
- DOI:
10.1007/s00415-020-09919-9 - 发表时间:
2020-05-23 - 期刊:
- 影响因子:4.600
- 作者:
Kiran Jayaprakash;Stella A. Glasmacher;Bernard Pang;Emily Beswick;Arpan R. Mehta;Rachel Dakin;Judith Newton;Siddharthan Chandran;Suvankar Pal - 通讯作者:
Suvankar Pal
Dielectric Measurements of Brain Tissues with Alzheimer’s Disease Pathology in the Microwave Region
微波区域中脑组织的介电测量与阿尔茨海默氏病病理学
- DOI:
10.1109/memea.2019.8802179 - 发表时间:
2019 - 期刊:
- 影响因子:0
- 作者:
Imran M. Saied;M. Bashri;T. Arslan;Colin Smith;Siddharthan Chandran - 通讯作者:
Siddharthan Chandran
Lineage-specific distribution of high levels of genomic
高水平基因组的谱系特异性分布
- DOI:
10.1038/cr.2011.113 - 发表时间:
2011-07-12 - 期刊:
- 影响因子:25.900
- 作者:
Alexey Ruzov;Yanina Tsenkina;Andrea Serio;Tatiana Dudnakova;Judy Fletcher;Yu Bai;Tatiana Chebotareva;Steve Pells;Zara Hannoun;Gareth Sullivan;Siddharthan Chandran;David C Hay;Mark Bradley;Ian Wilmut;Paul De Sousa - 通讯作者:
Paul De Sousa
Siddharthan Chandran的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Siddharthan Chandran', 18)}}的其他基金
University of Edinburgh Momentum Award – Dementias
爱丁堡大学动力奖 — 痴呆症
- 批准号:
MC_PC_16031 - 财政年份:2017
- 资助金额:
$ 34.24万 - 项目类别:
Intramural
Dementias Platform UK Stem Cell Partnership
痴呆症平台英国干细胞合作伙伴关系
- 批准号:
MR/N013255/1 - 财政年份:2016
- 资助金额:
$ 34.24万 - 项目类别:
Research Grant
Autologous adult human mesenchymal stem cells: a neuroprotective therapy for multiple sclerosis
自体成人间充质干细胞:多发性硬化症的神经保护疗法
- 批准号:
G0502107/1 - 财政年份:2006
- 资助金额:
$ 34.24万 - 项目类别:
Research Grant
相似国自然基金
LIPUS促进微环境巨噬细胞释放CCL2诱导尿道周围平滑肌祖细胞定植与分化的机制研究
- 批准号:82370780
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
骨髓抑制再生单个核细胞移植通过调节线粒体功能在脑缺血再灌注损伤中的神经保护机制研究
- 批准号:82371301
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
NRF2/MFN2/ERS信号异常促进ADSCs衰老和肥大型肥胖皮下脂肪组织胰岛素抵抗的机制研究
- 批准号:32000511
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
线粒体功能对涡虫干细胞命运决定调控机制的研究
- 批准号:32000498
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
m6A识别蛋白YTHDFs在体细胞重编程中的调控作用及机制研究
- 批准号:32000501
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
人干细胞分化和重编程过程中的R-环变化规律研究
- 批准号:32000500
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
核膜蛋白调节人干细胞稳态和衰老的机制研究
- 批准号:31900523
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
转录因子剂量效应调控体细胞重编程的表观遗传机制研究
- 批准号:31970681
- 批准年份:2019
- 资助金额:58.0 万元
- 项目类别:面上项目
lncRNA AC132217.4在人骨髓间充质干细胞成骨分化中的作用及机制研究
- 批准号:31900513
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
FTO在调节人干细胞稳态和衰老中的作用
- 批准号:31900524
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The effects of human lower limb immobilization on regenerative skeletal muscle stem cell characteristics in vitro
人体下肢固定对体外再生骨骼肌干细胞特性的影响
- 批准号:
MR/Y033787/1 - 财政年份:2024
- 资助金额:
$ 34.24万 - 项目类别:
Research Grant
CAREER: Mechano-Metabolic Control of Electrical Remodeling of Human Induced Pluripotent Stem Cell Derived Engineered Heart Muscle
职业:人类诱导多能干细胞衍生的工程心肌电重塑的机械代谢控制
- 批准号:
2338931 - 财政年份:2024
- 资助金额:
$ 34.24万 - 项目类别:
Standard Grant
A HUMAN IPSC-BASED ORGANOID PLATFORM FOR STUDYING MATERNAL HYPERGLYCEMIA-INDUCED CONGENITAL HEART DEFECTS
基于人体 IPSC 的类器官平台,用于研究母亲高血糖引起的先天性心脏缺陷
- 批准号:
10752276 - 财政年份:2024
- 资助金额:
$ 34.24万 - 项目类别:
DEVELOPING A HUMAN STEM CELL-DERIVED HEART MODEL TO CHARACTERIZE A NOVEL ARRHYTHMIA SYNDROME
开发人类干细胞衍生的心脏模型来表征新型心律失常综合征
- 批准号:
495592 - 财政年份:2023
- 资助金额:
$ 34.24万 - 项目类别:
Functional characterization of schizophrenia rare variants using genetically engineered human iPSCs
使用基因工程人类 iPSC 进行精神分裂症罕见变异的功能表征
- 批准号:
10554598 - 财政年份:2023
- 资助金额:
$ 34.24万 - 项目类别:
Using trained immunity-inhibiting nanobiologics to achieve tolerance of heart allografts in non-human primates
使用经过训练的免疫抑制纳米生物制剂来实现非人类灵长类动物同种异体心脏移植的耐受性
- 批准号:
10642598 - 财政年份:2023
- 资助金额:
$ 34.24万 - 项目类别:
Advancing human neural progenitor cells (hNPCs) to FDA IND approval
推动人类神经祖细胞 (hNPC) 获得 FDA IND 批准
- 批准号:
10642228 - 财政年份:2023
- 资助金额:
$ 34.24万 - 项目类别:
Regulation of human tendon development and regeneration
人体肌腱发育和再生的调节
- 批准号:
10681951 - 财政年份:2023
- 资助金额:
$ 34.24万 - 项目类别:
Engineering Human Organizer To Study Left-Right Symmetry Breaking
工程人类组织者研究左右对称性破缺
- 批准号:
10667938 - 财政年份:2023
- 资助金额:
$ 34.24万 - 项目类别:
Elucidating endolysosomal trafficking dysregulation induced by APOE4 in human astrocytes
阐明人星形胶质细胞中 APOE4 诱导的内溶酶体运输失调
- 批准号:
10670573 - 财政年份:2023
- 资助金额:
$ 34.24万 - 项目类别:














{{item.name}}会员




